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ABSTRACT
Background. The ATP-sensitive P2X7 receptor (P2X7R) has
been shown to contribute to renal injury in nephrotoxic nephritis,
a rodent model of acute glomerulonephritis, and in unilateral ure-
teric obstruction (UUO), a rodent model of chronic interstitial
inﬂammation and ﬁbrosis. Renal tubular cells, endothelial cells
and macrophages also express the closely related P2X4 receptor
(P2X4R), which is chromosomally co-located with P2X7R and
has 40% homology; it is also pro-inﬂammatory and has been
shown to interact with P2X7R to modulate its pro-apoptotic and
pro-inﬂammatory effects. Therefore, we chose to explore the func-
tion of P2X4R in the UUO model of renal injury using knockout
mice. We hypothesized that UUO-induced tubulointerstitial
damage and ﬁbrosis would also be attenuated in P2X4R−/−mice.
Method. P2X4R−/− and wild-type (WT) mice were subjected
to either UUO or sham operation. Kidney samples taken on
Days 7 and 14 were evaluated for renal inﬂammation and ﬁ-
brosis, and expression of pro-ﬁbrotic factors.
Results. To our surprise, the obstructed kidney in P2X4R−/−
mice showed more severe renal injury, more collagen depo-
sition (picrosirius red staining, increase of 53%; P < 0.05) and
more type I collagen staining (increase of 107%; P < 0.01), as
well as increased mRNA for TGF-β (increase of 102%, P <
0.0005) and CTGF (increase of 157%; P < 0.05) by Day 14,
compared with the UUOWT mice.
Conclusion. These ﬁndings showed that lack of P2X4R
expression leads to increased renal ﬁbrosis, and increased
expression of TGF-β and CTGF in the UUO model.
Keywords: connective tissue growth factor, P2X4 receptor,
renal ﬁbrosis, TGF-β, unilateral ureteric obstruction
INTRODUCTION
Extracellular purines and pyrimidines are important signalling
molecules that mediate diverse biological effects via cell surface
receptors known as purine receptors [1]. There are two main
types of purinergic receptors, P1 and P2: the ligand for P1 is
adenosine and for P2 ATP (adenosine 50-triphosphate), ADP
(adenosine 50-diphosphate), UDP (uridine 50-diphosphate) and
UTP (uridine 50-triphosphate). P2 receptors are divided into
two subclasses, P2X and P2Y: P2X are ligand-gated ion chan-
nels and P2Y are G protein-coupled receptors. Among the
seven mammalian P2X receptors, P2X7 (P2X7R) has been
shown to have pro-apoptotic and pro-inﬂammatory functions
in many tissues, including the kidney [2], as well as a potentially
proliferative and pro-ﬁbrotic function, demonstrated in the ne-
phrotoxic nephritis (NTN) [3] and unilateral ureteral obstruc-
tion (UUO) [4] models, respectively. Turner et al. [2] reported
up-regulation of P2X7R in human lupus-related GN and in
rodent models of GN. Taylor et al. [3] found that in the NTN
model of glomerulonephritis, P2X7R gene deﬁciency was reno-
protective when compared with wild-type (WT) controls; in
addition, the selective P2X7R antagonist A-438079 prevented
development of NTN in rats. Moreover, Gonçalves et al. [4]
showed in the UUO model that P2X7R deﬁcient mice had
signiﬁcantly attenuated tubulointerstitial injury.
Compared with P2X7R, the role of the chromosomally ad-
jacent and structurally related P2X4 receptor (P2X4R) in© The Author 2014. Published by Oxford University Press on behalf of ERA-
EDTA. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0/),
which permits unrestricted reuse, distribution, and reproduction in any medium,
provided the original work is properly cited.
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kidney injury is unknown [5]. P2X4R has a wider tissue distri-
bution than P2X7R, including in blood vessels, lung, kidney,
and, like P2X7R, immune cells [6]. P2X4R has been detected
at the mRNA level, and as expressed protein in a variety
of renal cell types, including glomerular mesangial [7] and
epithelial cells [8] and most tubular cells, especially proximal
tubular cells [7, 9], but also collecting duct cells [10, 11],
although it is worth noting that P2 receptor subtypes and their
distribution can vary by species [12]. However, P2X4R func-
tion along the nephron is still unclear, but at least two recent
studies have suggested a role in affecting distal nephron
sodium transport [13–15]. So far its function has been studied
mainly in the central and peripheral nervous systems, and in
the vasculature. P2X4R is involved in synaptic transmission in
neurons and has excitatory effects when bound to extracellular
ATP. Increased P2X4R expression in microglia has been ob-
served after spinal cord injury [16] and brain ischaemia [17].
In human vascular endothelial cells, P2X4R is involved in
ATP-induced Ca2+ inﬂux [18] and ﬂow-mediated vasodilata-
tion through nitric oxide release, affecting blood pressure and
vascular remodelling [19].
Published data have suggested that P2X4R and P2X7R may
exist as heterotrimers in certain tissues, including bone
marrow-derived macrophages [20], although interactions
between homotrimeric P2X7R and P2X4R seem more likely
[21]. Brone et al. [22] found evidence for P2X4 and P2X7 ion
channel currents in recruited peritoneal macrophages, and
that both receptors are expressed, and can functionally inter-
act, in murine macrophages [23]. Recently, Kawano et al. [23]
have shown that P2X7R-mediated inﬂammation is regulated
by co-expression with P2X4R through facilitation of IL-1β
release from a mouse macrophage cell line. Moreover, Gu et al.
[24] have provided evidence in the eye for an interaction
between P2X7R and P2X4R that determines the phenotypic
function of the macrophage and its clearance of apoptotic
cells, which could in turn affect ATP release from necrotic
cells following tissue damage. While the role of P2X7R in
renal pathology has been the main focus of recent interest, a
potential role for P2X4R has remained relatively unexplored;
however, ﬁndings to date suggest a close functional relation-
ship between P2X4R and P2X7R, and therefore a possible role
for P2X4R in renal injury [11].
In the present study, we have examined the role of P2X4R
in the UUO model of chronic inﬂammation and ﬁbrosis using
P2X4R knockout (KO) mice. We chose this model because a
previous study in UUO in P2X7R KO mice had shown a
reduction in renal inﬂammation and ﬁbrosis, and we had ex-
pected to ﬁnd similar protection in P2X4R KO mice; however,
surprisingly, we observed an increase in renal ﬁbrosis.
MATERIALS AND METHODS
Animals
P2X4R-deﬁcient mice were gifts from GlaxoSmithKline
and they have been described in detail elsewhere [25].
Age- and sex-matched WT mice of the same genetic back-
ground (C57BL/6) were used as controls. These mice were
obtained from Charles River UK animal suppliers (Kent,
UK). The growth rates of these animals were indistinguishable
from those of WT animals, and mutant mice reproduced
normally. All mice were male and aged 10–12 weeks. Animals
had free access to standard laboratory diet and water. Mice
were kept in a pathogen-free environment, and experiments
were performed according to institutional and UK Home
Ofﬁce guidelines.
Experimental design
The animals underwent either sham-operation or UUO
operation. Under sterile conditions, animals were anaesthe-
tized with a mixture of isoﬂurane and oxygen. Two ties were
knotted around the mid-portion of the left ureter, using a thin
non-absorbable suture (5/0, Mersilk) and the ureter was sec-
tioned between the ligatures. The abdomen was closed with
running sutures and the skin was closed with interrupted
sutures. Sham-operated animals underwent identical surgical
procedures, except that the left ureter was manipulated without
ligation and sectioning. The animals were killed at 7 days or
14 days after UUO. Each group consisted of six mice.
Tissue preparation
Samples of kidney were either unﬁxed or ﬁxed in periodate-
lysine-paraformaldehyde (PLP) and snap-frozen in isopentane
precooled in liquid nitrogen, or ﬁxed in neutral-buffered for-
malin and then embedded in parafﬁn for sectioning. Tissues
ﬁxed in neutral-buffered formalin were used for periodic-acid
Schiff (PAS) staining, Sirius-red staining (SR) and immunohis-
tochemistry for alpha-smooth muscle actin and collagen. Snap-
frozen tissues ﬁxed in PLP were used for CD68 staining for
macrophage detection.
Immunohistochemistry
To stain for CD68, endogenous peroxidase was blocked by
3% hydrogen peroxide for 10 min and then tissues were incu-
bated with a rat anti-mouse CD68 antibody (Serotec Ltd,
Oxford, UK, MCA 1957) for 1 h. For the detection, Polink-2
HRP plus rat DAB detection system (Dako, D46–15) was used
and the counterstain was done with haematoxylin. For detec-
tion of α-smooth muscle actin (α-SMA) and collagen I, stan-
dard immunohistochemical techniques were used. In brief,
tissue sections were rehydrated through xylene and graded
alcohols, boiled with 0.01 M sodium citrate buffer for 15 min,
and then sections were blocked for endogenous peroxidase
(Dako peroxidase block, 10 min, room temperature). Sections
were blocked in 10% Marvel milk for 30 min. The primary
antibodies were rabbit anti-α-SMA (1:500, ab 5694; Abcam,
Cambridge, UK), rabbit anti-collagen I (1:500, ab 34710;
Abcam, Cambridge, UK) and rabbit anti-P2X4R antibody
(1:2000, APR-002; Alomone labs, Jerusalem, Israel). They
were diluted in 1% goat serum and incubated for up to 6 h at
room temperature. For detection, Dako envision kit with
labelled polymer conjugated to goat anti-rabbit IgG (K 4011;
Dako, Ely, Cambridgeshire, UK) was used.
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Histology
In PAS-stained sections, tubulointerstitial injury was as-
sessed semi-quantitatively in a blinded fashion (modiﬁed from
Ophascharoensuk et al.) [26]. For each animal, 20 consecutive
high-power ﬁelds were scored for the presence of inﬂamma-
tory cells within the interstitium by the presence of tubular di-
latation, atrophy, and cast formation, and by the presence of
tubular basement membrane thickening and interstitial
widening (no damage = score 0; damage in <5% of HPF =
score 1; damage in 5–<25% of HPF = score 2; damage in 25–
50% of HPF = score 3; damage in >50% of HPF = score 4). The
mean tubulointerstitial damage score was calculated and used
for statistical analysis.
For the analysis for SR, CD68, α-SMA and collagen I, ﬁve
consecutive ﬁelds of cortex and ﬁve ﬁelds of medulla were cap-
tured under ×200 magniﬁcation using a Phototonic Science
Color Coolview camera (Photonic Sciences, Robertsbridge,
UK), and analysed using Image Pro 7 software (Media Cyber-
netis, Silver Spring, MD, USA). Images were converted to
grey-scale 256-bit images for the analysis for SR. A single ob-
server performed blinded morphological measurements.
Real-time quantitative PCR
Total RNA from kidney was isolated using TRIzol reagents
(Invitrogen, Paisley, UK). Two micrograms of RNA was
reverse-transcribed with the First Strand cDNA Synthesis Kit
for RT–qPCR (AMV) (Roche Applied Science, Burgess Hill,
UK). Real-time quantitative PCR (RT–qPCR) was performed
on the Mastercycler® ep realplex (Eppendorf, Histon, UK)
using the SYBR green master-mix (Thermo Scientiﬁc, Lough-
borough, UK). GAPDH or 18s rRNA served as the internal
control. The sequences of PCR primers used in this study are
listed in Table 1. The expression of mRNA was analysed by a
relative quantiﬁcation method, the 2-ΔΔCt method.
Statistical analysis
Data are given as mean ± S.D. Differences between groups
were analysed by Mann–Whitney U-test. All probabilities were
two tailed. P-values <0.05 were considered signiﬁcant.
Statistical analyses were performed using Prism 5.0 (Graph-
Pad, Software, La Jolla, CA, USA).
RESULTS
Expression of P2X4R
Expression of P2X4R protein and mRNA in renal tissue of
WT mice was studied by immunohistochemistry and RT–
qPCR, respectively. P2X4R protein was detected in kidney of
sham-operated WT mice (Figure 1A), showing linear positive
staining for P2X4R on the luminal surface of tubular epithelial
cells. Diffuse P2X4R expression was detected on tubular epi-
thelial cells at 7 and 14 days after induction of UUO in the
WT mice (Figure 1A). A signiﬁcant increase in P2X4R mRNA
was detected 7 days after induction of UUO (P = 0.0022) com-
pared with sham-operated mice (Figure 1B).
Tubulointerstitial injury
After 7 and 14 days of ureteral obstruction, UUO-operated
kidneys in all WTmice showed the typical features of obstructive
nephropathy, with tubular dilatation and cast formation, and
widespread tubulointerstitial damage, inﬂammation and ﬁbrosis.
Tubulointerstitial injury was assessed and scored on PAS-
stained tissues according to the severity of injury. There was a
signiﬁcant increase in tubulointerstitial injury in P2X4R−/−
UUO mice compared with WT UUO mice on Days 7 (P =
0.0047) and 14 (P = 0.026) (Figure 2A). No difference in tubu-
lointerstitial injury was detected between sham-operated
kidneys from P2X4R−/− and WT mice on Days 7 and 14.
Figure 2B shows the typical histological ﬁndings of obstructed
kidneys in each UUO group.
Next we assessed the potential inﬂuences of P2X4R on the
development of tubulointerstitial ﬁbrosis following UUO.
Tubulointerstitial ﬁbrosis
Extracellular matrix. Since UUO-operated kidneys typically
show increased interstitial expression of extracellular matrix, we
examined the expression of collagen and ﬁbronectin in kidney
tissue. We examined expression of collagen by SR staining.
Collagen ﬁbrils were identiﬁed using this staining method at
Days 7 and 14. There was no signiﬁcant difference in SR staining
between sham-operated P2X4R−/− and WT kidneys. There was
a progressive increase in SR staining in UUO from Day 7 to Day
14 in WT and P2X4R−/− mice; however, SR staining on Day 14
in UUO-operated kidneys was signiﬁcantly increased in
P2X4R−/− mice compared with WT UUO (increase of 53%;
P = 0.0152) (Figure 3A and B). To verify the SR staining results,
we examined the expression of collagen I by immunohistochem-
istry (Figure 4A and B). The pattern of collagen I staining was
consistent with SR staining. Day 14 UUO-operated kidneys
from P2X4R−/− mice expressed more collagen I (increase of
107%; P = 0.0087) when compared withWTUUOmice.
To investigate the renal expression of ﬁbronectin, renal
mRNA expression was examined by real-time RT–qPCR on
Days 7 and 14. There was no signiﬁcant difference in ﬁbronec-
tin mRNA expression between sham-operated kidneys of WT
and P2X4R−/− animals (Figure 5A). By Day 7, WT and
Table 1. Primers used in real-time RT–PCR ampliﬁcation
Gene Primer nucleotide sequences
MCP-1 Forward 50-CCTCTGGGCCTGCTGTTCA-30
Reverse 50-CCAGCCTACTCATTGGGATCA-30
TGF-β Forward 50-GCAACATGTGGAACTCTACCAGAA-30
Reverse 50-GACGTCAAAAGACAGCCACTCA-30
CTGF Forward 50-CAAAGCAGCTGCAAATACCA-30
Reverse 50-GGCCAAATGTGTCTTCCAGT-30
Fibronectin Forward 50-ACACGGTTTCCCATTACGCCAT-30
Reverse 50-AATGACCACTGCCAAAGCCCAA-30
GAPDH Forward 50-GCATGGCCTTCCGTGTTC-30
Reverse 50-GATGTCATCATACTTGGCAGGTTT-30
P2X4R Forward 50-CCCTTTGCCTGCCCAGATAT-30
Reverse 50-CCGTACGCCTTGGTGAGTGT-30
18s rRNA Forward 50-ACCGCGGTTCTATTTTGTTG-30
Reverse 50-CCCTCTTAATCATGGCCTCA-30
MCP-1, monocyte chemoattractant protein-1; TGF-β, transforming growth factor-β;
CTGF, connective tissue growth factor; GAPDH, glyceraldehyde 3-phosphate
dehydrogenase; 18s rRNA, 18s ribosomal ribonucleic acid.
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P2X4R−/− UUO mice showed higher expression of ﬁbronectin
mRNA than sham-operated mice; however, there was no sig-
niﬁcant difference between WT and P2X4R−/− UUO mice. By
Day 14, there was 84% higher expression of ﬁbronectin mRNA
in P2X4R−/− UUO mice compared with WT UUO mice,
although this did not reach statistical signiﬁcance.
Pro-ﬁbrotic growth factors. Since transforming growth
factor-β (TGF-β) and connective tissue growth factor (CTGF)
play a signiﬁcant role in the progression of renal ﬁbrosis in both
clinical and experimental renal disease, we examined the renal
expression of TGF-β and CTGF mRNA by real-time RT–PCR
on Days 7 and 14. The renal expression of TGF-β mRNA in
UUO-operated kidneys was higher in P2X4R−/− mice com-
pared with WT mice by Day 7 (increase of 21%; P = 0.065) and
by Day 14 (increase of 102%; P = 0.0004) (Figure 5B). No sig-
niﬁcant differences in TGF-β mRNA expression were seen in
sham-operated kidneys from WT or P2X4R−/− mice. The
pattern of expression of CTGF mRNA was similar to that of
TGF-β. The UUO-operated kidneys expressed signiﬁcantly
higher CTGF mRNA levels than the sham-operated kidneys. By
Day 14, CTGF mRNA was up-regulated in UUO-operated
kidneys of P2X4R−/− mice compared with WT UUO mice (in-
crease of 157%; P = 0.0496). There was no signiﬁcant difference
in CTGF mRNA expression between sham-operated kidneys
from WT or P2X4R−/− (Figure 5C). Higher expression of both
TGF-β and CTGF mRNA in P2X4R−/− mice following UUO
suggests a pro-ﬁbrotic effect of P2X4R deﬁciency.
Alpha-smooth muscle actin. Since myoﬁbroblasts may be in-
volved in renal ﬁbrosis, we performed immunohistochemistry
for α-SMA (Figure 6A and B). UUO-operated kidneys
expressed signiﬁcantly higher α-SMA than sham-operated
kidneys on Days 7 and 14 in both groups of animals. α-SMA-
positive staining in UUO-operated kidneys was 60% higher in
P2X4R−/− mice compared with WT mice on Day 14, although
the differences were not statistically signiﬁcant (P = 0.09).
The results of the analyses for renal collagen were consist-
ent with the expression of the pro-ﬁbrotic growth factors
TGF-β and CTGF. This ﬁnding indicates that deﬁciency of
P2X4R has a signiﬁcant effect on the promotion of tubuloin-
terstitial ﬁbrosis following UUO.
Renal MCP-1. We examined whether deﬁciency of P2X4R
affects renal expression of CCL2 [monocyte chemoattractant
protein-1 (MCP-1)]—a chemokine for macrophages—mRNA
by RT–qPCR. As shown in Figure 7A, MCP-1 mRNA was
highly expressed in UUO-operated kidneys compared with
sham-operated kidneys on Days 7 and 14. On Day 7, UUO-
operated kidneys from P2X4R−/− and WT mice showed no
signiﬁcant difference in MCP-1 mRNA expression, but by
Day 14, UUO-operated kidneys from P2X4R−/− mice ex-
pressed 62% higher MCP-1 mRNA levels compared with WT
mice (P = 0.0176). In the sham-operated kidneys, there was no
signiﬁcant difference in MCP-1 mRNA expression between
P2X4R−/− and WT kidneys on Day 7 or 14.
Renal macrophages. Macrophages have a role in inﬂam-
mation and ﬁbrosis, and express P2X4R, as well as P2X7R. Im-
munohistochemistry of renal tissue for macrophages using
anti-CD68 antibody on kidney tissue from Days 7 and 14 after
sham or UUO showed a signiﬁcant increase in CD68-positive
staining following UUO on Days 7 and 14 compared with
sham-operated kidneys, but no signiﬁcant difference between
WT and P2X4R−/− UUO on Day 7 or 14 (Figure 7).
F IGURE 1 : Expression of P2X4R following UUO: (A) Immunohistochemistry for P2X4R in WT mice following UUO: There was a linear
positive staining on the luminal surface of tubular epithelial cells in non-operated kidneys, whereas the positive staining was internalized after
7 and 14 days in UUO-operated kidneys. Original magniﬁcation ×70. (B) Increased expression of P2X4R mRNA following UUO detected
by RT–qPCR.
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DISCUSSION
Inﬂammation and ﬁbrosis underlie almost all forms of pro-
gressive renal disease, but what determines the balance and
shift between inﬂammation and ﬁbrosis is still poorly under-
stood [27]. Thus, the focus of current research into renal
pathophysiology has centred on these two key processes, and
in trying to identify the underlying factors that may control or
modify them.
F IGURE 2 : Tubulointerstitial injury following UUO: (A) Scoring of tubulointerstitial damage is signiﬁcantly higher in P2X4R−/−mice, in
comparison with WT mice after 7 and 14 days of UUO. (B) Histological ﬁndings of UUO kidney sections after 7 and 14 days of UUO stained by
periodic-acid Schiff. Original magniﬁcation ×80.
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Although P2X7R has been detected in renal tissue, includ-
ing tubular cells, its expression is normally at a very low level
[28], and any role for this receptor in the kidney seems more
likely to depend on its expression by resident or inﬁltrating
immune cells, particularly the macrophage [3]. Indeed, P2X7R
deﬁciency has been shown to attenuate renal injury in rodent
models of acute inﬂammatory glomerulonephritis [3], as well
as in the UUO model [4], in DOCA-salt hypertension [29]
and in a model of lupus nephritis [30]. In contrast, the func-
tion of P2X4R in the kidney is still unclear, but may include an
effect on sodium transport [13–15]. As already mentioned,
these receptors are structurally related and are often expressed
in the same cell; several recent reports have suggested physical
and functional interactions between these receptors when
F IGURE 3 : Effect of deﬁciency of P2X4R in the synthesis of collagen after UUO: (A) Sirius-red (SR) staining in P2X4R−/− was signiﬁcantly
greater compared with WT by Day 14 as quantiﬁed by image analysis. (B) SR staining of UUO kidney sections on Day 7 and 14 in different
groups. Original magniﬁcation ×70.
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expressed by immune cells, which may affect the inﬂammatory
response [9, 11, 31, 32]. It is perhaps also worth noting that in
contrast to P2X7R, which has a low afﬁnity for extracellular
ATP and requires a high concentration for its activation,
P2X4R is much more sensitive to ATP stimulation and can
also form a non-lethal pore that is permeable to large organic
molecules, but unlike P2X7R it can rapidly desensitize ATP
[33]. However, what these biophysical properties may lead to
in terms of biological function is still unclear.
Superﬁcially at least, these receptors might be expected to
have similar or overlapping functions; for example, both
P2X7R and P2X4R have been shown to cause NLRP3 inﬂam-
masome activation [30, 34, 35]. Therefore, in the present
study, we investigated the role of P2X4R in the development of
F IGURE 4 : Effect of deﬁciency of P2X4R in the synthesis of collagen I after UUO: (A) Immunostaining for collagen I was signiﬁcantly
greater in P2X4R−/− compared with WT by Day 14. (B) Immunostaining of UUO kidney sections for collagen I on Day 7 and 14. Original
magniﬁcation ×80.
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renal inﬂammation and ﬁbrosis following UUO, because of
their frequent co-localization in the same cell, especially
immune cells, as well as their structural, and possible functional,
relationship [27, 36, 37]. The effect of a new generation of
P2X4R antagonists has been reported from in vitro studies
[38], but it is not known whether they are suitable for in vivo
studies [39].
Thus, using P2X4R−/− mice, we hypothesized that UUO-
induced tubulointerstitial damage and ﬁbrosis should be atte-
nuated, as had been reported previously in P2X7R−/− mice.
However, we were surprised to ﬁnd more tubulointerstitial
damage and ﬁbrosis in P2X4R KO mice: renal ﬁbrosis in-
creased signiﬁcantly in P2X4R−/− by Day 14 compared with
WT mice, suggesting a pro-ﬁbrotic effect in the absence of
P2X4R. This observation is supported by the increased renal
expression of TGFβ1 and CTGF mRNA, and of type I collagen
deposition following UUO in P2X4R KO mice compared with
WT mice. However, the number of inﬁltrating macrophages,
which were similar on both Day 7 and Day 14, cannot explain
the differences in ﬁbrosis.
F IGURE 5 : Effect of deﬁciency of P2X4R in the expression of ﬁbronectin, TGF-β and CTGF in UUO: (A) The increase in expression of
ﬁbronectin mRNA in P2X4R−/− was not statistically signiﬁcant in comparison with WT by Day 14. (B) The expression of TGF-βmRNAwas
signiﬁcantly higher in P2X4R−/− compared with WT on Day 14. (C) By Day 14 the expression of CTGF mRNAwas signiﬁcantly higher in
P2X4R−/− compared with WT.
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Immunohistochemistry for P2X4R showed linear positive
staining on the luminal surface of tubular epithelial cells in
non-operated kidneys, whereas staining for this receptor was
more diffuse, including cytoplasmic, in UUO-operated
kidneys. P2X4R has been detected both at the plasma mem-
brane and in the cytoplasm of neurons, microglial cells and
macrophages [21]. Stimulation of primary microglia cells with
endotoxin for 3–6 h increased surface expression of P2X4R,
probably by increasing trafﬁcking to the membrane, as can
MCP-1 stimulation [40], a chemokine that is also induced by
P2X7R activation [3]. Exposure of neurons to extracellular
ATP increases the internalization of P2X4R rapidly [41]. In
F IGURE 6 : Effect of deﬁciency of P2X4R in the expression of α-SMA after UUO: (A) Immunostaining for α-SMA in P2X4R−/− compared
with WT on Day 7. The increase in α-SMA staining in P2X4R−/− only showed a trend. (B) Immunostaining of UUO kidney sections for
α-SMA on Day 7 and 14 in UUO kidneys. Original magniﬁcation ×80.
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the kidney, the trafﬁcking of P2X4R from the cell surface to
the cytoplasm may reﬂect a ligand-induced change during the
tubulointerstitial responses to UUO, although how this might
moderate the inﬂammatory response is unclear.
Cross-talk between renal epithelial cells has been demon-
strated in vitro for the P2X7R mediating interstitial ﬁbroblast
cell death following tubular cell injury and release of ATP [42],
but how P2X4R might be involved or modulate this effect has
F IGURE 7 : Effect of deﬁciency of P2X4R on renal MCP-1 and macrophages after UUO: (A) There was no signiﬁcant differences in MCP-1
mRNA expression on Day 7 (WT or P2X4R−/−). By day MCP-1 14 mRNA expression was signiﬁcantly higher in P2X4R−/− compared with
WT. (B) Immunostaining for CD68 shows no signiﬁcant differences between different groups on both Day 7 and Day 14.
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not been considered. The mesangial cell has some macro-
phage-like properties [43] and the macrophage itself may con-
tribute to renal ﬁbrosis. We did ﬁnd signiﬁcantly higher
expression of MCP-1 mRNA in P2X4R−/− mice by Day 14,
but the number of inﬁltrating macrophages did not differ sig-
niﬁcantly between KO and WT mice, although their function
may have altered.
Finally, a P2X4R-dependent vascular response might have
affected renal blood ﬂow, including the medullary circulation
[44], which in turn could have altered renal tissue oxygen-
ation, leading to more ﬁbrosis in the UUO model. The P2X4R
KO mouse is known to have a higher blood pressure and im-
paired ﬂow-mediated vasodilatation from reduced endothelial-
dependent nitric oxide release [19]. But again, we can only
speculate as to what role this might play in UUO, although the
presence of hypertension itself may predispose to more renal
injury.
In conclusion, we report the unexpected ﬁnding that
P2X4R deﬁciency increases renal ﬁbrosis in the UUO model,
which is in contrast to P2X7R. The accentuated ﬁbrotic
changes following UUO observed in P2X4R−/− mice require
further investigation, but serve to highlight a potential role for
this receptor in renal pathology, and its relationship to P2X7R
with which it may partner in regulating cell function when
co-expressed.
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